Special Report | Markets in Turmoil: Reopening
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
22 Maj 202044min
Coca-Cola CEO; NJ Governor on Reopening: Data Determines Dates
New Jersey is reopening its beaches just in time for Memorial Day Weekend. New Jersey Governor Phil Murphy explains his state’s strategy for getting back to business as the pandemic wages on. Plus Coc...
21 Maj 202032min
Special Report | Markets in Turmoil: Travel & Contact Tracing
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
21 Maj 202045min
Walmart CEO: When I think of the future, I think locally first
Doug McMillon, CEO of America’s largest brick-and-mortar retailer and one of the country’s biggest employers, discusses his company’s efforts to support Walmart’s current associates while simultaneous...
20 Maj 202032min
Special Report | Markets in Turmoil
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
20 Maj 202045min
Magic Johnson; Galatoire’s New Orleans; Main Street Recovery
NBA legend and entrepreneur Magic Johnson has teamed up with MBE Capital Partners CEO Rafael Martinez to deploy $100 million to fund loans for minority- and women-owned small businesses hit by the Cov...
19 Maj 202030min
Special Report | Markets in Turmoil: Vaccine Latest
Listen to CNBC's special report on how the novel Coronavirus outbreak is spreading in the United States, and how it's continuing to hit stock markets around the world. Hosted by Simplecast, an AdsWizz...
19 Maj 202044min
Racing for a Vaccine: Moderna’s Phase 1 Human Trial
Moderna CEO Stephane Bancel shares the first human data for a Covid-19 vaccine program. Early results from the study are promising, and the markets agree. Surgeon, author, and The New Yorker staff wri...
18 Maj 202034min
